LegiPlex
Legislation Monitoring
& Workspaces
US
Federal
& States
About
Sign Up
Login
...
US
US Federal US
Legislatures
2025-2026 Regular Session
House
Bills
HB3288
US
US Federal House Bill HB3288
US Federal 2025-2026 Regular Session
Overview
Activity Timeline
Videos
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Menu
US
US Federal 2025-2026 Regular Session
US Federal House Bill HB3288
Introduced
5/8/25
Refer
5/8/25
Caption
Access to Prescription Digital Therapeutics Act of 2025
Latest US HB3288 Activity
View All Events: US 2025-2026 Regular Session HB3288
Companion Bills
US SB1702
Related Access to Prescription Digital Therapeutics Act of 2025
Previously Filed As
US SB1702
Access to Prescription Digital Therapeutics Act of 2025
US HB950
Saving Seniors Money on Prescriptions Act
US HB1509
Accelerating Kids’ Access to Care Act of 2025
US SB418
Therapeutic interchange; authorizes pharmacists to perform, adaptation of prescriptions.
US SB00011
An Act Concerning Prescription Drug Access And Affordability.
US HB4623
Plain Prescription Prices Act
US HB2533
EASE Act of 2025 Ensuring Access to Specialty care Everywhere Act of 2025
US HB1433
Kids’ Access to Primary Care Act of 2025
US SB4070
Diabetes Foot Health Access and Modernization Act of 2026
US HB3211
Establishes the "Accessible Prescription Labels Act"
Similar Bills
US SB1702
Access to Prescription Digital Therapeutics Act of 2025
UT HB0264
Prescription Medication Amendments
VA HB2378
Therapeutically equivalent drug products; provisions for return of outdated drugs.
RI H5626
Mandates health insurance coverage for FDA approved contraceptive drug, device or therapeutic equivalent.
RI S0480
Mandates health insurance coverage for FDA approved contraceptive drug, device or therapeutic equivalent.
VA SB418
Therapeutic interchange; authorizes pharmacists to perform, adaptation of prescriptions.
MT HB399
Revise prior authorization laws
RI H5855
Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals."